102 related articles for article (PubMed ID: 8137377)
21. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.
Löwenberg B; Wagemaker G; van Bekkum DW; Sizoo W; Sintnicolaas K; Hendriks WD; Hagenbeek A
Bone Marrow Transplant; 1986 Dec; 1(2):133-40. PubMed ID: 3332128
[TBL] [Abstract][Full Text] [Related]
22. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
23. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
24. Autologous mixed lymphocyte reaction in man. XII. Deficiency of the autologous mixed lymphocyte reaction in patients undergoing allogeneic bone marrow transplantation. Relationship with chronic graft-versus-host disease.
Gupta S; Kapoor N; O'Reilly R; Good RA
J Clin Lab Immunol; 1984 Aug; 14(4):173-5. PubMed ID: 6238167
[TBL] [Abstract][Full Text] [Related]
25. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
26. Graft-versus-host disease after marrow transplantation.
Storb R
Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
[TBL] [Abstract][Full Text] [Related]
27. Prediction by a modified mixed leukocyte reaction assay of graft-versus-host disease and graft rejection after allogeneic bone marrow transplantation.
Bishara A; Brautbar C; Nagler A; Slavin S; Leshem B; Cohen I; Kedar E
Transplantation; 1994 May; 57(10):1474-9. PubMed ID: 8197610
[TBL] [Abstract][Full Text] [Related]
28. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
29. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Schmitz N; Beksac M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szerm J; Bradstock K; Buzyn A; Schlegelberger B; Matcham J; Gratwohl A
Haematologica; 2005 May; 90(5):643-8. PubMed ID: 15921379
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
31. Colonic cryptosporidiosis in allograft patients: a rare differential diagnosis of acute graft-versus-host disease.
Gauchotte G; Bressenot A
Hum Pathol; 2010 Jun; 41(6):918-9; author reply 919-20. PubMed ID: 20466123
[No Abstract] [Full Text] [Related]
32. Lung function changes after allogenic bone marrow transplantation.
Link H; Reinhard U; Blaurock M; Ostendorf P
Thorax; 1986 Jul; 41(7):508-12. PubMed ID: 3538484
[TBL] [Abstract][Full Text] [Related]
33. Simple diagnosis of graft-versus-host disease.
Hiraoka A; Kawakami M; Fukuda H; Nakamura H; Karasuno T; Teshima H; Masaoka T
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S70-2. PubMed ID: 9440548
[TBL] [Abstract][Full Text] [Related]
34. Intravenous IgG to prevent graft-versus-host disease after bone marrow transplantation.
N Engl J Med; 1991 Feb; 324(9):631-3. PubMed ID: 1992325
[No Abstract] [Full Text] [Related]
35. Imaging the complications of bone marrow transplantation in children.
Levine DS; Navarro OM; Chaudry G; Doyle JJ; Blaser SI
Radiographics; 2007; 27(2):307-24. PubMed ID: 17374855
[TBL] [Abstract][Full Text] [Related]
36. Differential diagnosis between graft-versus-host disease and hemophagocytic syndrome after living-related liver transplantation by mixed lymphocyte reaction assay.
Hara H; Ohdan H; Tashiro H; Itamoto T; Tanaka Y; Mizunuma K; Tokita D; Onoe T; Ito R; Asahara T
J Invest Surg; 2004; 17(4):197-202. PubMed ID: 15371161
[TBL] [Abstract][Full Text] [Related]
37. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period.
Walker SA; Riches PG; Rogers TR; White S; Hobbs JR
J Clin Pathol; 1984 Sep; 37(9):1022-6. PubMed ID: 6381552
[TBL] [Abstract][Full Text] [Related]
38. T and B cell deficiencies in patients with chronic graft-versus-host disease after HLA-identical marrow transplantation.
Lum LG; Seigneuret MC; Storb R; Witherspoon RP; Thomas ED
Transplant Proc; 1981 Mar; 13(1 Pt 2):1231-2. PubMed ID: 7022930
[No Abstract] [Full Text] [Related]
39. Myositis associated with graft-versus-host disease.
Parker PM; Openshaw H; Forman SJ
Curr Opin Rheumatol; 1997 Nov; 9(6):513-9. PubMed ID: 9375280
[TBL] [Abstract][Full Text] [Related]
40. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.
Walker SA; Rogers TR; Riches PG; White S; Hobbs JR
J Clin Pathol; 1984 Sep; 37(9):1018-21. PubMed ID: 6381551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
